Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,107 | 269 | 99.4% |
| Entertainment | $19.18 | 1 | 0.5% |
| Education | $7.68 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $726.49 | 40 | $0 (2024) |
| Daiichi Sankyo Inc. | $446.49 | 50 | $0 (2019) |
| PFIZER INC. | $359.34 | 38 | $0 (2021) |
| Purdue Pharma L.P. | $246.98 | 21 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $217.86 | 13 | $0 (2022) |
| Boston Scientific Corporation | $165.85 | 3 | $0 (2024) |
| ASSERTIO THERAPEUTICS, Inc. | $160.67 | 5 | $0 (2019) |
| Kaleo, Inc. | $122.85 | 9 | $0 (2019) |
| PROTEGA PHARMACEUTIALS INC | $107.29 | 5 | $0 (2023) |
| Arbor Pharmaceuticals, Inc. | $105.00 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.00 | 3 | Boston Scientific Corporation ($140.81) |
| 2023 | $124.93 | 7 | PROTEGA PHARMACEUTIALS INC ($39.47) |
| 2022 | $297.46 | 13 | PROTEGA PHARMACEUTIALS LLC ($67.82) |
| 2021 | $205.85 | 11 | Collegium Pharmaceutical, Inc. ($113.82) |
| 2020 | $219.25 | 12 | Collegium Pharmaceutical, Inc. ($111.82) |
| 2019 | $817.01 | 59 | Collegium Pharmaceutical, Inc. ($142.16) |
| 2018 | $1,047 | 56 | Collegium Pharmaceutical, Inc. ($182.99) |
| 2017 | $1,247 | 112 | Daiichi Sankyo Inc. ($294.50) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $140.81 | General |
| 10/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Opioid Analgesic | ||||||
| 05/10/2024 | Avanos Medical | STANDARD RF DISPOSABLES (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | Fidia Pharma USA Inc. | HYMOVIS (Device), TRILURON | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: OSTEOARTHRITIS | ||||||
| 09/14/2023 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/23/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: Pain | ||||||
| 02/13/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/30/2023 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Pain Management | ||||||
| 01/20/2023 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Pain Management | ||||||
| 12/12/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $22.89 | General |
| Category: Endocrinology | ||||||
| 12/09/2022 | PROTEGA PHARMACEUTIALS LLC | Roxybond (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Pan Management | ||||||
| 10/27/2022 | PROTEGA PHARMACEUTIALS LLC | Roxybond (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Pan Management | ||||||
| 10/22/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: Pain Management | ||||||
| 10/17/2022 | PROTEGA PHARMACEUTIALS LLC | Roxybond (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Pan Management | ||||||
| 07/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Gastroenterology | ||||||
| 06/09/2022 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/16/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Opioid Analgesic | ||||||
| 04/27/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $24.50 | General |
| 04/11/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Opioid Analgesic | ||||||
| 02/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: non-opioid analgesic | ||||||
| 08/19/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 339 | 794 | $411,070 | $61,888 |
| 2022 | 6 | 611 | 1,866 | $984,909 | $168,190 |
| 2021 | 4 | 704 | 1,971 | $1.0M | $179,153 |
| 2020 | 6 | 734 | 2,710 | $1.5M | $204,938 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 702 | $374,810 | $56,171 | 15.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 77 | 77 | $30,800 | $4,689 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $5,460 | $1,028 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 347 | 1,594 | $852,790 | $146,806 | 17.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 156 | 156 | $62,400 | $9,493 | 15.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 34 | $24,378 | $4,837 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $19,159 | $2,693 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $12,012 | $2,226 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $14,170 | $2,136 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 402 | 1,662 | $889,170 | $155,827 | 17.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 191 | 194 | $77,600 | $11,950 | 15.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 60 | 60 | $49,980 | $7,625 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 55 | $20,020 | $3,752 | 18.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 527 | 2,453 | $1.3M | $184,498 | 14.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 73 | 73 | $60,809 | $9,354 | 15.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 76 | 90 | $32,760 | $4,683 | 14.3% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2020 | 13 | 29 | $19,169 | $2,295 | 12.0% |
| J3490 | Unclassified drugs | Office | 2020 | 13 | 33 | $16,500 | $2,173 | 13.2% |
| 80307 | Testing for presence of drug | Office | 2020 | 32 | 32 | $12,800 | $1,936 | 15.1% |
About Dr. Lance Cassell, M.D
Dr. Lance Cassell, M.D is a Pain Medicine healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205058328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Cassell, M.D has received a total of $4,134 in payments from pharmaceutical and medical device companies, with $175.00 received in 2024. These payments were reported across 273 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,107).
As a Medicare-enrolled provider, Cassell has provided services to 2,388 Medicare beneficiaries, totaling 7,341 services with total Medicare billing of $614,169. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Sarasota, FL
- Active Since 05/02/2007
- Last Updated 04/25/2024
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1205058328
Products in Payments
- XTAMPZA (Drug) $506.76
- Movantik (Drug) $256.67
- Morphabond ER (Drug) $241.04
- LYRICA (Drug) $240.09
- RELISTOR ORAL (Drug) $129.98
- RELISTOR (Drug) $122.62
- Gralise (Drug) $119.49
- Xtampza ER (Drug) $110.20
- Horizant (Drug) $105.00
- Amitiza (Drug) $104.43
- Senza Spinal Cord Stimulation System (Device) $86.81
- PRIALT (Drug) $84.86
- HYSINGLA ER (Drug) $83.91
- ARYMO ER (Drug) $81.31
- XTAMPZAER (Drug) $72.07
- Roxybond (Drug) $67.82
- Evzio (Drug) $67.41
- ZOHYDRO ER (Drug) $64.73
- Aimovig (Biological) $61.72
- LUCEMYRA (Drug) $61.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Sarasota
Priti Vohra, Do, DO
Pain Medicine — Payments: $21,025
Douglas Constant, Md, MD
Pain Medicine — Payments: $7,031
Paul Beebe, M.d, M.D
Pain Medicine — Payments: $3,399
William Cole, D.o, D.O
Pain Medicine — Payments: $3,091
Kathryn Flavin, M.d, M.D
Pain Medicine — Payments: $2,708
Sandeep Kola, D.o, D.O
Pain Medicine — Payments: $2,577